Back to search
FDAFDA · Food and drugs·Recall number D-0725-2022

Avaphinal Maximum Male Enhancement Sexual Pills, 2000 MG*, packaged in 10 Capsules per carton.

Published March 23, 2022 · Recall initiated: February 9, 2022

Summary

FDA records drug Class I recall D-0725-2022, published March 23, 2022 and initiated February 9, 2022. Recalling firm: Walmart Stores; Status: Terminated; Reported quantity: unknown; Lot: Lot: DK1027, Exp 08/01/2023. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Walmart Stores
Distributor
Nationwide in the USA via www.walmart.com
Lot
Lot: DK1027, Exp 08/01/2023
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Avaphinal Maximum Male Enhancement Sexual Pills, 2000 MG*, packaged in 10 Capsules per carton. recalled?

Yes. FDA published recall D-0725-2022 on March 23, 2022. Reported hazard: Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail